Paradox Immunotherapeutics
Manufacturing · Canada · 1-10 Employees
View Company Info for Free
Overview
Headquarters
100 College St Ste 150, Toronto, Ontario...Website
www.paradoximmuno.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1
About Paradox Immunotherapeutics
Paradox Immunotherapeutics is an pharmaceutical company developing immunotherapies for rare diseases using a proven-successful immunotherapy drug design platform. The company designs drugs that harness the bodys own immune system to clear lethal deposits from affected organs and reverse organ damage. The company's team has a successful history in designing drug candidates for amyloidosis and taking them from bench to bedside. Using the same platform technology, the company's lead candidate includes a potential treatment for immunoglobulin light chain (AL) cardiac amyloidosis. Their other discovery pipelines include treatments for chronic renal failure and neurodegenerative diseases. With a team of experts in immunotherapy drug design, they possess an orphan drug discovery platform, termed "The PARADOX Platform" for the potential treatment of ~30 rare diseases, a platform technology which has already sparked the interest of major players in the pharmaceutical industry.Explore more
Paradox Immunotherapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Paradox Immunotherapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Paradox Immunotherapeutics is spiking on competitors!
Click to see if Paradox Immunotherapeutics had a recent Job posting/layoffs
Earning: See what the market has to say on Paradox Immunotherapeutics recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Paradox Immunotherapeutics
Product Launch: Get notified when Paradox Immunotherapeutics launches new products
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Paradox Immunotherapeutics has new funding data
Paradox Immunotherapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Paradox Immunotherapeutics has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined Paradox Immunotherapeutics as Masked Content
Find 3 more new buyers
Compare Similar Companies to Paradox Immunotherapeutics
Compare insights from companies similar to Paradox Immunotherapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Paradox Immunotherapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Paradox Immunotherapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Paradox Immunotherapeutics.
Paradox Immunotherapeutics financials insights
Gather financial insights about Paradox Immunotherapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2025
Other Financing Round
$10M
Paradox Immunotherapeutics Tech Stack
A closer look at the technologies used by Paradox Immunotherapeutics
See more technologies
Most Recent Scoops
Event
Events, Engineering, Sales, Bioengineering, Laboratory Operations, Pharmaceuticals, Field /Outside Sales, Clinical Operations, Field Marketing, Operations
Event
Events, Engineering, Sales, Bioengineering, Laboratory Operations, Pharmaceuticals, Field /Outside Sales, Clinical Operations, Field Marketing, Operations
Funding
Funding
Funding
Paradox Immunotherapeutics News & Media
Paradox Immunotherapeutics Appoints Sandy Zweifach as Executive Chairman
TORONTO--(BUSINESS WIRE)--Paradox Immunotherapeutics (“Paradox”), a pharmaceutical company focused on the development of innovative antibody therapies that treat rare protein misfolding diseases, today announced it has appointed Sandy Zweifach as Executive Chairman, effective immediately. Mr. Zweifach has been a founder and senior executive in the life sciences industry for more than 30 years with a focus in corporate partnering, business development, operations, private and public investing, a
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Paradox Immunotherapeutics
Sign Up For FreeTo access detailed company insights
Paradox Immunotherapeutics is an pharmaceutical company developing immunotherapies for rare diseases using a proven-successful immunotherapy drug design platform. The company designs drugs that harness the bodys own immune system to clear lethal deposits from affected organs and reverse organ damage. The company's team has a successful history in d... Read More
